Dexamethasone - Glenmark Pharmaceuticals Europe Ltd
Glenmark Pharmaceuticals Europe Ltd.
Description
Suppression of inflammatory and allergic disorders by mouth
• Child: 10–100 mcg/kg daily in 1–2 divided doses.
• Adult: 0.5–10 mg daily.
Mild croup by mouth
Child: 150 mcg/kg for 1 dose
Severe croup by mouth
Child: initially 150 mcg/kg before transfer to hospital, then an additional dose, then another after 12 hours if required.
Dyspnoea due to bronchospasm or partial obstruction in palliative care
Adult: 4–8 mg daily.
Indications
For the suppression of inflammatory and allergic disorders and croup.
Contraindications
Use with caution in the case of hepatic or renal impairment.
Preparations Available
Soluble tablet
Price
Soluble tablets
2 mg, 50 tablets, sugar free
4 mg, 50 tablets, sugar free
8 mg, 50 tablets, sugar free
Glensoludex 2 mg, 50 tablets
Glensoludex 4 mg, 50 tablets
Glensoludex 8 mg, 50 tablets
More on: Corticosteroids , Dexamethasone